299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

7 trials found

diseases per page:

Showing 1 to 7 of 7 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2009-009869-34-SE (EUCTR)	12/10/2009	29/07/2009	Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy ...	Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy ...	Idiopathic and post-pneumonic non-Cystic Fibrosis Bronchiectasis in pulmonary stable patients (defin ...	Product Name: Cipro Inhale Product Code: BAYq3939 INN or Proposed INN: Ciprofloxacin	Bayer HealthCare AG	NULL	Not Recruiting			Female: yes Male: yes	122		United Kingdom;Germany;Spain;Sweden
2	EUCTR2009-009869-34-GB (EUCTR)	02/09/2009	09/04/2009	Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy ...	Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy ...	Idiopathic and post-pneumonic non-Cystic Fibrosis Bronchiectasis in pulmonary stable patients (defin ...	Product Name: Cipro Inhale Product Code: BAYq3939 INN or Proposed INN: Ciprofloxacin	Bayer HealthCare AG	NULL	Not Recruiting			Female: yes Male: yes	122		Germany;United Kingdom;Spain;Sweden
3	EUCTR2009-009869-34-ES (EUCTR)	03/07/2009	06/05/2009	Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy ...	Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy ...	Idiopathic and post-pneumonic non-Cystic Fibrosis Bronchiectasis in pulmonary stable patients (defin ...	Product Name: Cipro Inhale Product Code: BAYq3939 INN or Proposed INN: Ciprofloxacin	Bayer HealthCare AG	NULL	Not Recruiting			Female: yes Male: yes	120	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Spain;Germany;United Kingdom;Sweden
4	NCT00910351 (ClinicalTrials.gov)	July 2009	28/5/2009	Cipro Inhaler for Cystic Fibrosis Children Ages 6-12	A Study to Evaluate the Safety and Pharmacokinetics of Ciprofloxacin in Adults and Children Aged 6 - ...	Pseudomonas Infection	Drug: Ciprofloxacin (Cipro, BAYQ3939)	Bayer	NULL	Completed	6 Years	12 Years	Both	19	Phase 1	United States
5	EUCTR2009-009869-34-DE (EUCTR)	08/06/2009	17/03/2009	Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy ...	Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy ...	Idiopathic and post-pneumonic non-Cystic Fibrosis Bronchiectasis in pulmonary stable patients (defin ...	Product Name: Cipro Inhale Product Code: BAYq3939 INN or Proposed INN: Ciprofloxacin	Bayer HealthCare AG	NULL	Not Recruiting			Female: yes Male: yes	122		Spain;Germany;United Kingdom;Sweden
6	NCT00930982 (ClinicalTrials.gov)	June 2009	30/6/2009	Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis	Randomized, Placebo-controlled, Double-blind, Multi-center Study to Evaluate the Safety and Efficacy ...	Bronchiectasis	Drug: Ciprofloxacin (Cipro, BAYQ3939);Drug: Placebo	Bayer	Novartis	Completed	18 Years	N/A	All	124	Phase 2	United States;Australia;Germany;Spain;Sweden;United Kingdom
7	NCT00645788 (ClinicalTrials.gov)	May 2008	26/3/2008	Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosi ...	Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy ...	Cystic Fibrosis	Drug: Ciprofloxacin (Cipro Inhale, BAYQ3939);Drug: Placebo	Bayer	Novartis	Completed	12 Years	N/A	All	288	Phase 2	United States;Australia;Canada;Denmark;Germany;Israel;Norway;Sweden;United Kingdom

First Previous1Next Last